Found 5 matching trials
Evaluating the Safety and Protective Efficacy of a Single Dose of a Trivalent Live Attenuated Dengue Vaccine to Protect Against Infection With DENV-2
PHASE1Infection with dengue viruses is the leading cause of hospitalization and d...
Location
Center for Immunization Research (CIR), Johns Hopkins School of Public Health
Dengue Controlled Human Infection Model in Dhaka, Bangladesh
PHASE2The primary objective is to determine, among dengue-naΓ―ve adults in an ende...
Status
Active Not Recruiting
Evaluating the Safety and Immune Response to a Dengue Virus Vaccine in Healthy Adults
PHASE1Dengue viruses can cause dengue fever and other more serious illnesses. The...
Location
John Hopkins Bloomberg School of Public Health - Center for Immunization Research (CIR)
Evaluating the Clinical and Immune Response to Two Dengue Virus Vaccines in Healthy Adults
PHASE1Dengue viruses infect millions of people throughout the tropics and subtrop...
Location
Center for Immunization Research, Johns Hopkins School of Public Health
Evaluation of the Efficacy of the Live Attenuated Tetravalent Dengue Vaccine Against DENV-2 and DENV-3 Challenge
PHASE1The purpose of this study is to evaluate the ability of a single dose of a ...
Location
Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health